F. Wright

发表

Correlation Analysis of Variables From the Atherosclerosis Risk in Communities Study

Stephen W. Edwards, Cataia L. Ives, Yi‐Hui Zhou, 2022, Frontiers in Pharmacology.

Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies

Dereje D. Jima, Audrey Y. Chu, Toshiko Tanaka, 2022, American journal of human genetics.

Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis.

M. Rosenfeld, M. Bamshad, K. Hetrick, 2022, American journal of human genetics.

MagicalRsq: Machine-learning-based genotype imputation quality calibration

Daniel R. Schrider, M. Bamshad, Yi‐Hui Zhou, 2022, American journal of human genetics.

A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies

M. Corey, J. Zieleński, M. Drumm, 2011, Pediatric pulmonology.

Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients

M. Bamshad, Yun Li, E. Pugh, 2021, bioRxiv.

Rare loss of function variants in candidate genes and risk of colorectal cancer

Taylor J. Maxwell, Jennifer G. Robinson, Andrew J. Sanford, 2018, Human Genetics.

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole Genome Analysis of 7,840 Patients.

M. Rosenfeld, M. Bamshad, Yun Li, 2023, American journal of respiratory and critical care medicine.

Understanding the population structure of North American patients with cystic fibrosis

M. Corey, F. Zou, L. Strug, 2011, Clinical genetics.

seeQTL: a searchable database for human eQTLs

Fred A. Wright, Wei Wang, Patrick F. Sullivan, 2011, Bioinform..

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2

Fred A. Wright, Fei Zou, Clayton W. Commander, 2011, Nature Genetics.